NCT01838148 Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia
| NCT ID | NCT01838148 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2004-05 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2004-05 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim is to perform the largest study worldwide to evaluate novel biochemical and electrocardiographic signatures alone as well as in combination with the standard 12-lead exercise ECG in the detection of exercise-induced myocardial ischemia (diagnostic endpoint). The secondary aim is to evaluate these innovative tools in the risk prediction for the occurrence of cardiovascular death and acute myocardial infarction during long-term follow-up.
Eligibility Criteria
Inclusion Criteria: * Patients presenting with suspected exercise-induced myocardial ischemia referred for rest/ergometry myocardial perfusion SPECT Exclusion Criteria: * Age \< 18 years * Pregnancy * Unable or unwilling to give informed consent * Symptoms at rest or minor exertion
Contact & Investigator
Christian Mueller, Prof. Dr. MD
PRINCIPAL INVESTIGATOR
University Hospital, Basel, Switzerland
Frequently Asked Questions
Who can join the NCT01838148 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01838148 currently recruiting?
Yes, NCT01838148 is actively recruiting participants. Contact the research team at Christian.Mueller@usb.ch for enrollment information.
Where is the NCT01838148 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT01838148 clinical trial?
NCT01838148 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Christian Mueller, Prof. Dr. MD at University Hospital, Basel, Switzerland. The trial plans to enroll 4,000 participants.